Xinyuan Zhang

Affiliations:
  • University of Texas Health Science Center at Houston, USA


According to our database1, Xinyuan Zhang authored at least 12 papers between 2017 and 2023.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2023
DEVO: an ontology to assist with dermoscopic feature standardization.
BMC Medical Informatics Decis. Mak., December, 2023

2021
Developing Ontologies to Standardize Descriptions of Visual and Dermoscopic Elements.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2021

2020
On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients.
Health Informatics J., 2020

Statistical Impact of Sample Size and Imbalance on Multivariate Analysis in silico and A Case Study in the UK Biobank.
Proceedings of the AMIA 2020, 2020

2019
Comparing drug safety of hepatitis C therapies using post-market data.
BMC Medical Informatics Decis. Mak., 2019

Real world scenarios in rare variant association analysis: the impact of imbalance and sample size on the power in silico.
BMC Bioinform., 2019

Detecting potential pleiotropy across cardiovascular and neurological diseases using univariate, bivariate, and multivariate methods on 43, 870 individuals from the eMERGE network.
Proceedings of the Biocomputing 2019: Proceedings of the Pacific Symposium, 2019

2018
Collective feature selection to identify crucial epistatic variants.
BioData Min., 2018

Comparing Pharmacovigilance Outcomes Between FAERS and EMR Data for Acute Mania Patients.
Proceedings of the IEEE International Conference on Healthcare Informatics Workshops, 2018

Comparing adverse effects of Hepatitis C drugs using FAERS data.
Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine, 2018

2017
Comparing Different Adverse Effects Among Multiple Drugs Using FAERS Data.
Proceedings of the MEDINFO 2017: Precision Healthcare through Informatics, 2017

Post-marketing Drug Safety Evaluation Using Data Mining Based on FAERS.
Proceedings of the Data Mining and Big Data - Second International Conference, 2017


  Loading...